FINWIRES · TerminalLIVE
FINWIRES

Murata Manufacturing Dishes Out Higher Final Dividend for Fiscal Year 2026

By

Murata Manufacturing (TYO:6981) declared a year-end dividend of 35 yen per share for the fiscal year 2025, matching earlier forecasts and higher than the 30 yen per share paid a year ago.

The total dividend payment amounts to 63.7 billion yen, payable from retained earnings on June 30, according to a Tokyo bourse filing on Tuesday.

The company's basic policy for returning profits to shareholders is to prioritise dividend payments, with a target of achieving a dividend on equity of 5% by 2027.

For the fiscal year 2026, Murata Manufacturing forecasts full-year dividends of 65 yen per share, consisting of an interim dividend of 30 yen and a year-end dividend of 35 yen.

Related Articles

Asia

Market Chatter: China Aluminum Sector Prepares for Impact of Guinea's Bauxite Export Restrictions

The Chinese aluminum sector is bracing for the impact on its raw supplies following Guinea's plans to limit its bauxite exports, Bloomberg reported Monday.The West African nation, the world's largest bauxite producer, will lay out its measures to control its exports as global prices of the ore slumped, the report said, citing Mines and Geology Minister Bouna Sylla.Guinea's shipments of the ore surged to 183 million tons, helping lower costs for Chinese aluminum companies, Bloomberg said."Supply mustn't exceed demand," the news outlet quoted the minister as saying, adding Guinea has to regulate export quantities to bring back prices to "reasonable levels."(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^SSEC$^SZSE
Asia

China Aircraft Leasing's Unit Sells Airbus Aircraft

China Aircraft Leasing Group's (HKG:1848) wholly-owned special purpose vehicle agreed to sell an Airbus A321-200 aircraft to YIELDCAP NO.1 (TIANJIN) LEASING, according to a Tuesday Hong Kong bourse filing.The transaction is expected to be completed on or before Oct. 31.

$HKG:1848
Asia

CSPC Pharma Gets Registration Nod for Ulcer Drug in China

CSPC Pharmaceutical (HKG:1093) obtained drug registration approval for its Lansoprazole Enteric-coated Capsules from China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The product is indicated to treat gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, and anastomotic ulcer.

$HKG:1093